Rznomics Inc. Secures Orphan Drug Designation from FDA for RZ-001
Rznomics Inc. Secures Fast Track Designation from the U.S. FDA for RZ-001
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance